Sharescart Research Club logo
Products
Research
Tools
About
Join Channel

Divi's Lab

₹6175.5 59.1 | 1%

Last updated: 15:50

Consolidated Standalone

Last updated: 15:50

Divi's Lab Overview

Divi's Laboratories Ltd manufactures Active Pharma Ingredients (APIs) and intermediates. The organization in a matter of short time multiplied their breadth of operations to offer whole turnkey solutions to the domestic Indian pharmaceutical enterprise.They are actively concerned in growing trade, patent non-infringing approaches for APIs, for the inventors to control late life cycle and leading customary drug producers.The company's product variety includes Bupropion Hbr,Bupropion HCL,Capecitabine,Carbidopa,Desloratadine,Dexlansoprazole /(R)-L...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Divi's Lab Key Financials

Market Cap ₹163940 Cr.

Stock P/E 74.8

P/B 10.6

Current Price ₹6175.5

Book Value ₹ 580.6

Face Value 2

52W High ₹7077.7

Dividend Yield 0.49%

52W Low ₹ 4941.7

Edit Ratio

Divi's Lab Share Price

₹ | |

Volume
Price

Divi's Lab Quarterly Price

Quarterly Monthly
Show Value Show %

Divi's Lab Peer Comparison

Divi's Lab Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 1778 1909 1855 2303 2118 2338 2319 2585 2410 2715
Other Income 81 86 95 79 79 106 82 86 119 145
Total Income 1859 1995 1950 2382 2197 2444 2401 2671 2529 2860
Total Expenditure 1274 1430 1366 1572 1496 1622 1576 1699 1681 1827
Operating Profit 585 565 584 810 701 822 825 972 848 1033
Interest 0 1 0 2 0 1 0 1 3 8
Depreciation 93 95 95 95 97 99 99 107 112 113
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 492 469 489 713 604 722 726 864 733 912
Provision for Tax 136 121 131 175 174 212 137 202 188 223
Profit After Tax 356 348 358 538 430 510 589 662 545 689
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 356 348 358 538 430 510 589 662 545 689
Adjusted Earnings Per Share 13.4 13.1 13.5 20.3 16.2 19.2 22.2 25 20.6 26

Divi's Lab Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 3115 3776 4064 3891 4946 5394 6969 8960 7767 7845 9360 10029
Other Income 45 97 75 113 156 190 63 116 345 339 352 432
Total Income 3160 3874 4139 4005 5102 5584 7032 9076 8112 8184 9712 10461
Total Expenditure 1949 2358 2617 2629 3073 3571 4108 5079 5398 5639 6391 6783
Operating Profit 1211 1516 1522 1376 2029 2013 2924 3997 2714 2545 3321 3678
Interest 3 5 3 2 5 7 2 2 2 4 3 12
Depreciation 136 118 123 142 169 186 256 312 343 378 402 431
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1072 1393 1395 1231 1855 1819 2666 3684 2369 2163 2916 3235
Provision for Tax 221 267 335 354 502 443 682 723 545 563 725 750
Profit After Tax 852 1126 1060 877 1353 1377 1984 2960 1824 1600 2191 2485
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 852 1126 1060 877 1353 1377 1984 2960 1824 1600 2191 2485
Adjusted Earnings Per Share 32.1 42.4 39.9 33 51 51.9 74.8 111.5 68.8 60.4 82.7 93.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 19% 1% 12% 12%
Operating Profit CAGR 30% -6% 11% 11%
PAT CAGR 37% -10% 10% 10%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 4% 30% 10% 20%
ROE Average 15% 14% 19% 21%
ROCE Average 20% 19% 25% 27%

Divi's Lab Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 3495 4293 5357 5925 6957 7310 9295 11728 12767 13571 14969
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 1 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 841 85 1412 1769 991 295 364 437 557 611 500
Total Current Liabilities 776 520 659 653 847 1821 1728 2454 1539 1755 2248
Total Liabilities 5112 4898 7429 8347 8795 9425 11387 14619 14863 15937 17717
Fixed Assets 1309 1439 1559 1996 2088 2782 3704 4325 4722 4739 5442
Other Non-Current Assets 1031 432 1859 1816 2057 1070 892 684 391 1046 1398
Total Current Assets 2772 3027 4011 4535 4650 5574 6791 9610 9750 10152 10877
Total Assets 5112 4898 7429 8347 8795 9425 11387 14619 14863 15937 17717

Divi's Lab Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 15 18 -17 -4 -21 2 43 2030 1215 170 363
Cash Flow from Operating Activities 826 1038 1150 776 954 1216 1947 1912 2459 1261 1653
Cash Flow from Investing Activities -521 -406 -1140 -478 -685 -83 75 -2195 -2707 -269 -804
Cash Flow from Financing Activities -303 -631 2 -314 -246 -1091 -35 -532 -797 -799 -799
Net Cash Inflow / Outflow 3 0 13 -17 23 41 1987 -816 -1045 193 50
Closing Cash & Cash Equivalent 18 18 -4 -21 2 43 2030 1215 170 363 413

Divi's Lab Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 32.08 42.41 39.95 33.04 50.96 51.86 74.75 111.53 68.83 60.38 82.68
CEPS(Rs) 37.2 46.86 44.59 38.41 57.32 58.87 84.38 123.26 81.77 74.64 97.85
DPS(Rs) 20 10 10 10 16 16 20 30 30 30 30
Book NAV/Share(Rs) 131.67 161.73 201.82 223.2 262.09 275.38 350.15 441.82 481.77 512.11 564.87
Core EBITDA Margin(%) 37.12 37.28 35.24 32.27 37.6 33.41 40.92 43.18 30.3 27.96 31.56
EBIT Margin(%) 34.21 36.73 34.06 31.53 37.33 33.48 38.16 41 30.32 27.46 31.03
Pre Tax Margin(%) 34.12 36.61 33.98 31.47 37.24 33.35 38.13 40.98 30.3 27.41 31
PAT Margin (%) 27.1 29.59 25.82 22.41 27.15 25.23 28.38 32.94 23.33 20.28 23.29
Cash Profit Margin (%) 31.43 32.69 28.83 26.06 30.54 28.64 32.04 36.4 27.71 25.07 27.56
ROA(%) 18.21 22.49 17.21 11.12 15.78 15.11 19.07 22.77 12.37 10.39 13.02
ROE(%) 26.37 28.91 21.98 15.55 21 19.3 23.9 28.16 14.89 12.15 15.35
ROCE(%) 33.06 35.57 28.75 21.68 28.5 25.36 32.07 35.06 19.36 16.46 20.45
Receivable days 85.12 77.83 79.19 89.33 79.78 86.18 80.66 83.26 98.42 91.33 94.81
Inventory Days 121.69 113.7 112.34 124.56 114.41 121.62 104.66 100.99 136.04 143.02 124.55
Payable days 56.95 55.71 80.72 101.95 90.34 93.73 106.32 95.88 93.12 92.5 84.95
PER(x) 27.9 23.23 15.62 32.98 33.42 38.33 48.56 39.49 41.05 56.92 69.83
Price/Book(x) 6.8 6.09 3.09 4.88 6.5 7.22 10.37 9.97 5.87 6.71 10.22
Dividend Yield(%) 1.12 1.02 1.6 0.92 0.94 0.81 0.55 0.68 1.06 0.87 0.52
EV/Net Sales(x) 7.62 6.92 4.07 7.42 9.14 9.76 13.52 12.73 9.1 11.1 15.95
EV/Core EBITDA(x) 19.59 17.23 10.86 20.98 22.28 26.17 32.22 28.54 26.04 34.22 44.95
Net Sales Growth(%) 23.02 21.23 7.63 -4.25 27.1 9.06 29.2 28.56 -13.31 1 19.31
EBIT Growth(%) 8.16 30.01 0.08 -11.8 50.75 -1.78 46.07 38.13 -35.67 -8.6 34.7
PAT Growth(%) 10.11 32.21 -5.81 -17.3 54.24 1.76 44.15 49.19 -38.39 -12.28 36.94
EPS Growth(%) 10.11 32.21 -5.8 -17.3 54.24 1.76 44.15 49.19 -38.28 -12.28 36.94
Debt/Equity(x) 0.01 0.01 0.01 0.01 0.02 0 0 0 0 0 0
Current Ratio(x) 3.57 5.83 6.08 6.94 5.49 3.06 3.93 3.92 6.34 5.78 4.84
Quick Ratio(x) 2.08 3.5 4.08 4.87 3.4 2.04 2.69 2.76 4.39 3.97 3.4
Interest Cover(x) 373.59 294.75 416.28 520.55 397.38 255.83 1270.54 1842.75 1185.5 541.75 973
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Divi's Lab Shareholding Pattern

# Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 51.93 51.92 51.92 51.9 51.89 51.89 51.89 51.89 51.89 51.88
FII 14.6 14.86 14.68 16.16 17.25 17.99 18.01 19.74 19.39 20.08
DII 21.75 21.88 22.21 21.77 21.06 20.54 20.7 19.05 19.76 19.28
Public 11.73 11.34 11.19 10.18 9.8 9.59 9.39 9.32 8.96 8.76
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Divi's Lab News

Divi's Lab Pros & Cons

Pros

  • Debtor days have improved from 92.5 to 84.95days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 14% over the last 3 years.
  • Stock is trading at 10.6 times its book value.
  • The company has delivered a poor profit growth of 9% over past five years.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!